The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 38 (2) , 304-312
Abstract
No abstract availableKeywords
Funding Information
- Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain
This publication has 35 references indexed in Scilit:
- Protection in Animal Models of Brain and Spinal Cord Injury with Mild to Moderate HypothermiaJournal of Neurotrauma, 2009
- Mechanisms of Control of Neuron Survival by the Endocannabinoid SystemCurrent Pharmaceutical Design, 2008
- Prominent Role of the Spinal Central Pattern Generator in the Recovery of Locomotion after Partial Spinal Cord InjuriesJournal of Neuroscience, 2008
- Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post‐natal rats through cannabinoid receptor 1 and cannabinoid receptor 2European Journal of Neuroscience, 2007
- The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn RatsPediatric Research, 2007
- Endocannabinoids: synthesis and degradation2006
- Therapeutic Action of Cannabinoids in a Murine Model of Multiple SclerosisJournal of Neuroscience, 2003
- Imaging in chronic spinal cord injury—indications and benefitsEuropean Journal of Radiology, 2002
- Quantitative MRI of spinal cord injury in a rat modelMagnetic Resonance in Medicine, 1994
- MRI characterization of diffusion coefficients in a rat spinal cord injury modelMagnetic Resonance in Medicine, 1994